miltefosine has been researched along with opc-67683 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Blaser, A; Denny, WA; Franzblau, SG; Gupta, S; Launay, D; Ma, Z; Maes, L; Martin, D; O'Connor, PD; Thompson, AM; Wan, B; Wang, Y; Yardley, V | 1 |
| Ang, CW; Blaskovich, MAT; Cooper, MA; Jarrad, AM | 1 |
| Alves, MA; Andrade-Neto, VV; Costa, DS; Costa, PRR; Cunha-Júnior, EF; Dias, AG; Fairlamb, AH; Goulart, MOF; Pacheco, JDS; Santos, DC; Silva, TL; Torres-Santos, EC; Wyllie, S | 1 |
1 review(s) available for miltefosine and opc-67683
| Article | Year |
|---|---|
Nitroimidazoles: Molecular Fireworks That Combat a Broad Spectrum of Infectious Diseases.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Communicable Diseases; Humans; Nitroimidazoles; Parasitic Diseases | 2017 |
2 other study(ies) available for miltefosine and opc-67683
| Article | Year |
|---|---|
Repositioning Antitubercular 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazoles for Neglected Tropical Diseases: Structure-Activity Studies on a Preclinical Candidate for Visceral Leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Antitubercular Agents; Cricetinae; Drug Repositioning; Female; High-Throughput Screening Assays; Hydrogen-Ion Concentration; Leishmania infantum; Leishmaniasis, Visceral; Mesocricetus; Mice; Mice, Inbred BALB C; Microsomes, Liver; Models, Molecular; Solubility; Structure-Activity Relationship | 2016 |
Monocyclic Nitro-heteroaryl Nitrones with Dual Mechanism of Activation: Synthesis and Antileishmanial Activity.
Topics: | 2021 |